“In-Silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues As Dual Inhibitors Targeting Breast Cancer”. Asian Journal of Pharmaceutical and Health Sciences 11, no. 2 (June 30, 2021): 2468–2474. Accessed October 15, 2025. https://ajphs.com/index.php/ajphs/article/view/126.